Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed Mar 15, 2017 · 10-K · 74 days after period end · 0001558370-17-001797
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Revenue | $2.36M | $4.94M | — |
| Net Income | -$14.67M | -$7.28M | — |
| EPS Diluted | $0.57 | $0.67 | $6.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 15, 2017 · 74 d after period end
